EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
California State Teachers Retirement System Buys 27,274,128 Shares of Moderna, Inc. $MRNA
Moderna (NASDAQ:MRNA) Shares Up 6.7% - Should You Buy?
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat
New FDA Drug Approvals - August 2026
AI Discovers Revolutionary Lung Drug That Makes People 3 Years "Younger" After Just 4 Weeks of Use
Amundi Reduces Stock Holdings in Moderna, Inc. $MRNA
Healthcare Stocks To Add to Your Watchlist - September 10th - Stock Observer
Influenza A Market Insight, Epidemiology, and Market Forecast - 2036 Now Available - See Why a 70% Vaccine Failure Rate Is Fueling the Race for Next-Gen Flu Therapies
Murphy Pohlad Asset Management LLC Makes New Investment in Moderna, Inc. $MRNA - Markets Daily
West Virginia meat processor struggling under weight of tariffs & high beef prices
Cancer vaccines could transform treatment and prevention
Nykredit A S Invests $913,000 in Moderna, Inc. $MRNA
AI helps create drug that may slow down ageing by 6 years in few weeks
Swapped Lives: The 15-Year Fork in the Road Between Moderna and BioNTech
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
Promising Biotech Stocks To Consider - September 7th - Zolmax
The Second Act of Biotech
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
Moderna, Inc. (NASDAQ:MRNA) Receives Average Recommendation of "Hold" from Brokerages - Markets Daily
How Is Moderna's Stock Performance Compared to Other Healthcare Stocks
NEOS Investment Management LLC Purchases 5,811 Shares of Moderna, Inc. $MRNA - Daily Political
MRNA, PHVS and ABBV Stocks: 3 Healthcare Plays for the Next Week, Year and Decade
AlphaGrep UK Ltd Invests $568,000 in Moderna, Inc. $MRNA
Moderna (NASDAQ:MRNA) Cut to Sell at Rothschild & Co Redburn
Healthcare Stocks To Consider - September 5th - Stock Observer
Moderna, Inc. $MRNA is Step Capital Management Pte. Ltd.'s 2nd Largest Position - Markets Daily
Step Capital Management Pte. Ltd. Has $48.67 Million Stake in Moderna, Inc. $MRNA
22,477 Shares in Moderna, Inc. $MRNA Acquired by AXQ Capital LP
Moderna (MRNA) Stock Trades Above Fair Value After Its 479% Run
Proficio Capital Partners LLC Takes $298,000 Position in Moderna, Inc. $MRNA - Stock Observer
What Does Moderna (MRNA) Bird Flu Phase 3 Trial Mean For Its Growth?
Can anything bring sky-high airline prices down? The Points Guy weighs in
Moderna (MRNA) Stock Looks Expensive On Sales After A Very Large Run
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?
Moderna's updated COVID-19 vaccine will target Omicron XFG variant
GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says
Healthcare Overtakes AI to Become Hedge Funds' Largest Holding
Why Moderna (MRNA) Stock Is Down Today
RGEN: Cancer Vaccine Exposure And Bioprocess Deals Will Shape Outlook
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
Moderna (MRNA) Price Forecast: Bullish Pennant Points Toward Higher Targets
Moderna (NASDAQ:MRNA) Insider Sells $485,766.45 in Stock
Moderna (MRNA) Started A Phase 3 Bird Flu Vaccine Trial
Best Healthcare Stocks To Research - September 3rd
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?
3 Stocks Whose Competitive Walls Tower Over Nvidia's
This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks
Moderna (NASDAQ:MRNA) Shares Gap Down on Analyst Downgrade
Rothschild & Co Redburn Downgrades Moderna (NASDAQ:MRNA) to Sell
Here Are Thursday's Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More
Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says
Biotech Stocks To Follow Now - September 3rd - Daily Political
Domestically Developed Universal Immune Priming Therapy Launches Clinical Program - Targeting "Cold Tumors" Unresponsive to PD-1 Treatments
WHO's Tedros says Ebola response must be scaled up to tackle Congo outbreak
Updated COVID-19 vaccines are coming this fall. Will insurance cover them?
Jim Cramer Explains Why Heavily Shorted Moderna (MRNA) Has Room to Run
Is BioNTech Stock a No-Brainer Buy on the Dip?
Top Value Stocks To Follow Today - September 2nd - Stock Observer
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
US Stock Market Today: S&P 500 Futures Slip As Rising Yields Pressure Equities
Brookline Capital Markets Forecasts Moderna Q3 Earnings - Stock Observer
Did Merck's (MRK) First Positive Phase 3 Individualized mRNA Cancer Trial Just Redefine Its Moat?
Traders Buy Large Volume of Call Options on Moderna (NASDAQ:MRNA) - Markets Daily
Stock Market Today, Sept. 1: Stocks Slide and Oil Surges Amid U.S.-Iran Tension
Moderna Target of Unusually Large Options Trading (NASDAQ:MRNA) - Stock Observer
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III
Moderna (NASDAQ:MRNA) Trading 3.6% Higher - Here's What Happened
GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial
S&P 500 biggest August 2026 winners: Moderna, software stocks
Moderna FY2029 EPS Lowered by Brookline Capital Markets
Van ECK Associates Corp Trims Stake in Moderna, Inc. $MRNA
Moderna Stock More Than Doubled in August. Is the Stock a Buy, a Hold, or a Sell?
Moderna (MRNA) Soars 156% in August - Here's What Propelled The Rally
Wellington Management Group LLP Boosts Stock Holdings in Moderna, Inc. $MRNA - Daily Political
Financings: Ausperbio's $120M series C; Moderna's $2.6B private placement | BioWorld
New COVID-19 vaccines approved for 2026-27 to combat latest active viruses | News & Features | ArcaMax Publishing
Inside the scramble to regulate AI
5 deals that fueled African music's global takeover
Best Biotech Stocks Worth Watching - August 31st - Daily Political
Alyeska Investment Group L.P. Trims Stake in Moderna, Inc. $MRNA
Moderna, Inc. (NASDAQ:MRNA) Given Average Rating of "Hold" by Brokerages
Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck's Trial Results Encouraging
The sudden unraveling of Wall Street's momentum trade
Best Value Stocks To Watch Now - August 30th - Markets Daily
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
